All stories tagged :

Pr Newswire

Immuthera’s Scientific Advisory Board: World-Leading Expertise Driving Next-Generation Diabetes and Immunotherapy...

admin
Pr Newswire

Folicure DFW Non-Surgical Hair Replacement New Resource: What Are Your Options...

admin
Pr Newswire

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

admin
Pr Newswire

Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical...

admin
Pr Newswire

Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year...

admin
Pr Newswire

Leadership change fuels Busways’ strategic ambitions

admin
Pr Newswire

Nature’s Miracle Holding Inc. Announces Receipt of Delisting Notification from Nasdaq

admin
Pr Newswire

Solidion Technology’s Chief Science Officer Delivers Keynote at Prestigious Advanced Materials...

admin
Pr Newswire

Verkada Expands Leadership Team to Drive JAPAC Channel Growth

admin
Pr Newswire

Supermicro Empowers AI-driven Capabilities for Enterprise, Retail, and Edge Server Solutions

admin
Pr Newswire

Instil Bio Announces Clinical Progress in China for IMM2510/SYN-2510, a Clinical-Stage...

admin

Featured

Pr Newswire

Virbac : Declaration of the number of shares and voting rights...

admin
Pr Newswire

Nxera Pharma to Receive US$4.8 Million in Milestone Payments Following Centessa’s...

admin
Pr Newswire

AB Science: Masitinib receives FDA and EMA authorization for confirmatory phase...

admin
Pr Newswire

Strüngmann Award Honors Araris Biotech Founding Team as 2025 Winner

admin
admin

Virbac : Declaration of the number of shares and voting rights...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital(Article 223-16 of the General regulations of the French Financial Market Authority – Autoritédes Marchés Financiers) Quotation place: Euronext ParisCompartiment AISIN code: FR0000031577 DateTotal...